New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
Silva JC, César FA, de Oliveira EM, Turato WM, Tripodi GL, Castilho G, Machado-Lima A, de Las Heras B, Boscá L, Rabello MM, Hernandes MZ, Pitta MG, Pitta IR, Passarelli M, Rudnicki M, Abdalla DS.
Silva JC, et al.
Pharmacol Res. 2016 Feb;104:49-60. doi: 10.1016/j.phrs.2015.12.010. Epub 2015 Dec 17.
Pharmacol Res. 2016.
PMID: 26706782